DOI QR코드

DOI QR Code

Case of Donor Cell Leukemia after Allogenic Bone Marrow Transplantation for Severe Aplastic Anemia

중증 재생불량성 빈혈에 대한 동종골수이식 후에 발생한 기증세포백혈병 1예

  • Kim, Eun Jeong (Division of Hematology, Department of Internal Medicine, Kosin University Gospel Hospital) ;
  • Kim, Yang Soo (Division of Hematology, Department of Internal Medicine, Kosin University Gospel Hospital) ;
  • Lee, Ho Seop (Division of Hematology, Department of Internal Medicine, Kosin University Gospel Hospital) ;
  • Lee, Eun Mi (Division of Hematology, Department of Internal Medicine, Kosin University Gospel Hospital) ;
  • Park, I Cheon (Division of Hematology, Department of Internal Medicine, Kosin University Gospel Hospital) ;
  • Lee, Weon Hyoung (Division of Hematology, Department of Internal Medicine, Kosin University Gospel Hospital) ;
  • Kim, Mi Hyang (Department of Laboratory Medicine, Kosin University Gospel Hospital)
  • 김은정 (고신대학교복음병원 혈액내과) ;
  • 김양수 (고신대학교복음병원 혈액내과) ;
  • 이호섭 (고신대학교복음병원 혈액내과) ;
  • 이은미 (고신대학교복음병원 혈액내과) ;
  • 박이천 (고신대학교복음병원 혈액내과) ;
  • 이원형 (고신대학교복음병원 혈액내과) ;
  • 김미향 (고신대학교복음병원 진단검사의학과)
  • Received : 2013.06.06
  • Accepted : 2013.09.01
  • Published : 2014.04.01

Abstract

Globally, there have been a small number of donor cell leukemia cases reported but, to our knowledge, none have been reported in Korea until now. Donor cell leukemia is a rare though well-recognized complication that occurs after allogenic hematopoietic stem cell transplantation (allo-HSCT). Herein, we report the case of an 18-year-old woman who developed acute lymphoblastic leukemia originating from donor cells after allo-HSCT.

본 증례는 중증재생불량성빈혈 환자에서 동종 조혈모세포이식 후 발생한 기증세포백혈병에 관한 보고이다. 기증세포백혈병은 드문 질환이지만 동종 조혈모세포이식 후 발생할 수 있는 합병증 중의 하나로 잘 알려져 있으며 진단에 있어서 세포유전적 분석 외에도 최근 short tandem repeats (STR) 혹은 variable number of tandem repeats (VNTR) 등의 분자적 분석기술의 발달로 진단이 용이해질 수 있다. 국내에서는 중증재생불량성빈혈 환자에서 동종골수이식 후에 발생한 기증세포기원의 급성 림프구성 백혈병이 보고된 바가 없고 저자들이 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

Keywords

References

  1. Deeg JH. Delayed complications after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Boston: Blackwell, 1994:538-544.
  2. Fialkow PJ, Thomas ED, Bryant JI, Neiman PE. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971;1:251-255.
  3. Hertenstein B, Hambach L, Bacigalupo A, et al. Development of leukemia in donor cells after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005;90:969-975.
  4. Perla G, Bodenizza C, Falcone A, et al. Misleading cytogenetic evidence of relapse in donor cells after allogeneic bone marrow transplantation corrected by fluorescent in situ hybridization. Haematologica 1995;80:292-293.
  5. Naoe T, Kiyoi H, Yamanaka K, Naito K, Yamada K. A case of cALL relapse after allogeneic BMT: recurrence of recipient cell origin, initially determined as being that of donor cell origin by sex chromosome analysis. Br J Haematol 1989;73:420-422. https://doi.org/10.1111/j.1365-2141.1989.tb07766.x
  6. Spinelli O, Giussani U, Borleri G, et al. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica 2000;85:1153-1157.
  7. Murata M, Ishikawa Y, Ohashi H, et al. Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review. Int J Hematol 2008;88:111-115. https://doi.org/10.1007/s12185-008-0094-3
  8. Ruiz-Arguelles A. Donor cell leukemia. Hematology 2012;17(Suppl 1):69-71.

Cited by

  1. A Case of Donor Cell Leukemia after Allogenic Peripheral Blood Stem Cell Transplantation for Acute Promyelocytic Leukemia with PML-RARA vol.10, pp.1, 2014, https://doi.org/10.3343/lmo.2020.10.1.88